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Defining late onset occult asymptomatic
cardiotoxicity in childhood cancer survivors
exposed to anthracycline therapy: a cardiac
magnetic resonance imaging study
Olga H Toro-Salazar1,8*, Kan N Hor2, Michael O’Loughlin3, Georgine Burke4, Jeff A Stainsby6, Eileen Gillan7,8,
Bruce T Liang5, Michael Taylor2
From 16th Annual SCMR Scientific Sessions
San Francisco, CA, USA. 31 January - 3 February 2013
Background
There are over 270,000 childhood cancer survivors in
the US. Of these survivors, more than 50% have been
treated with anthracyclines and are at risk of developing
progressive cardiotoxicity. Novel cardiac magnetic reso-
nance imaging (CMRI) techniques are now able to reli-
ably detect diffuse myocardial fibrosis and changes in
regional myocardial function. We hypothesized that
these novel CMRI techniques will identify occult asymp-
tomatic cardiotoxicity in a cohort of childhood cancer
survivors with normal global systolic function.
Methods
Twenty seven long-term childhood cancer survivors
between 11.8-28.8 years with a cumulative dose >240mg/
m2 (mean 363±89) and normal systolic function (SF>29%)
were studied 2.4-24 years after exposure to anthracycline
therapy. Patients underwent CMRI techniques to charac-
terize changes in T1 relaxation time, left ventricular myo-
cardial peak circumferential and longitudinal strain
parameters and were analyzed using the 17-segment
model. Extracellular volume (ECV) was measured in 13
subjects all of whom were late gadolinium enhancement
(LGE) negative. We performed standard CMRI assessment
and quantification of myocardial mass, end-systolic and
end-diastolic volumes, ejection fraction, and end systolic
fiber stress.
Results
Twenty seven of 60 planned subjects have been imaged.
End systolic fiber stress was significantly increased with
higher cumulative anthracycline dose (R2=0.18, p<0.03)
and younger age at diagnosis (R2=0.20, p<0.02). Lower
average circumferential strain magnitude (εcc) and regio-
nal changes in peak circumferential strain were seen in
multiple segments despite normal values of global sys-
tolic function by echocardiography and CMRI (Figure1).
T1 maps are depicted in Figure 1. The mean T1 values of
the myocardium were not significantly different between
patients and controls at 4 min (375±67ms vs.389±36,
p<0.07) and 10 min (433±52 ms vs.435±36, p<0.39), but
were significantly lower at 20 minutes (455±50ms vs. 487
±44, p<0.003) (Figure 2). Low myocardial T1 at 20 minutes
was significantly associated with increases in end systolic
fiber stress (R2=0.7, p<0.002). Higher mean ECV was
observed in patients with cumulative dose ≥400mg/m2
(0.27 vs. 0.21, p<0.05).
Conclusions
In this study we demonstrate that changes in T1 mapping-
derived relaxation time and left ventricular myocardial peak
circumference strain are present in asymptomatic post-che-
motherapy childhood patients who have normal standard
CMRI parameters. Circumferential strain analysis and mea-
surement of the T1 myocardial relaxation time by CMRI
may accurately identify occult cardiovascular dysfunction in
patients exposed to high dose anthracyclines. Thus, this
may aid in the evaluation of therapies aimed at reducing
adverse cardiac remodeling and preventing heart failure in
childhood cancer survivors exposed to anthracyclines.
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